CombiMatrix Corporation (NASDAQ: CBMX)

CombiMatrix Corporation (NASDAQ: CBMX) is a diversified biotechnology company focused on developing proprietary technologies, products and services in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology research, defense and homeland security markets, as well as other potential markets. Their unique technology has a wide range of potential applications in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences and nanotechnology. For further information, visit the Company’s web site at www.combimatrix.com.